INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

97 studies · page 4 of 5

2006 / Multicenter, double-blind, randomized controlled trial

Glucosamine and chondroitin sulfate, alone or combined, did not significantly reduce knee osteoarthritis pain overall compared to placebo.

In the GAIT trial, 1,583 patients with symptomatic knee osteoarthritis were randomized to receive 1500 mg glucosamine, 1200 mg chondroitin sulfate, both, 200 mg celecoxib, or placebo daily for 24 weeks. Overall, response rates were not significantly higher than placebo (60.1%) for glucosamine (+3.9 percentage points, P=0.30), chondroitin sulfate (+5.3 percentage points, P=0.17), or the combination (+6.5 percentage points, P=0.09), whereas celecoxib was significantly higher (+10.0 percentage points, P=0.008). In an exploratory subgroup with moderate-to-severe baseline pain, combined therapy had a significantly higher response rate than placebo (79.2% vs. 54.3%, P=0.002).

Clegg DO, Reda DJ, Harris CL, et al. N Engl J Med, 2006. PMID 16495392

2006 / Randomized controlled trial

Caloric restriction reduced bone mineral density, whereas exercise-induced weight loss preserved it.

A randomized trial of 48 adults aged 57 +/- 3 years evaluated 1-year changes in bone mineral density across caloric restriction, exercise, or a healthy lifestyle control. Caloric restriction decreased bone mineral density at the total hip (-2.2% +/- 3.1%), intertrochanter (-2.1% +/- 3.4%), and spine (-2.2% +/- 3.3%) compared to controls. Conversely, exercise-induced weight loss did not result in bone loss at any site despite comparable reductions in body weight.

Villareal DT, Fontana L, Weiss EP, et al. Arch Intern Med, 2006. PMID 17159017

2005 / Randomized crossover trial

A high-protein diet increased calcium absorption and urinary calcium without negatively impacting net bone balance in healthy women.

Thirteen healthy women completed a randomized crossover study comparing 10 days of a moderate-protein diet (1.0 g/kg) to a high-protein diet (2.1 g/kg) following a 2-week lead-in diet. Intestinal calcium absorption increased on the high-protein diet compared to the moderate-protein diet (26.2 +/- 1.9% vs. 18.5 +/- 1.6%, P < 0.0001), as did urinary calcium (5.23 +/- 0.37 vs. 3.57 +/- 0.35 mmol/d, P < 0.0001). The high-protein diet significantly reduced the fraction of urinary calcium of bone origin, showed a nonsignificant trend toward lower bone turnover, and had no effect on net bone balance.

Kerstetter JE, O'Brien KO, Caseria DM, et al. J Clin Endocrinol Metab, 2005. PMID 15546911

2005 / Randomized controlled trial

A low-energy diet induced rapid weight loss and improved knee osteoarthritis symptoms.

Eighty obese patients with knee osteoarthritis were randomized to an intensive low-energy diet (3.4 MJ/day) with weekly counseling or a control diet (5 MJ/day) with written guidance. The low-energy group lost 11.1% of body weight compared to 4.3% in controls (difference 6.8%, 95% CI: 5.5 to 8.1%, P < 0.0001). Total WOMAC scores improved in the low-energy cohort (mean difference -219.3 mm, P = 0.005), and every 1% reduction in body fat predicted a 9.4% improvement in symptoms.

Christensen R, Astrup A, Bliddal H Osteoarthritis Cartilage, 2005. PMID 15639633

2005 / Randomized controlled trial

Calcium supplementation boosts bone accretion during puberty, but some effects diminish later.

In a randomized trial of 354 females enrolled at pubertal stage 2, participants received approximately 670 mg/day of supplemental calcium or placebo over up to 7 years. Supplementation significantly increased all measured bone mineral density endpoints at year 4. By year 7, the benefit vanished for total-body and distal radius bone mineral density, though significant effects remained at metacarpal sites.

Matkovic V, Goel PK, Badenhop-Stevens NE, et al. Am J Clin Nutr, 2005. PMID 15640478

2005 / Randomized, double-blind, placebo-controlled trial

Chondroitin sulfate treatment for 2 years significantly reduced joint space loss compared to placebo in patients with knee osteoarthritis.

In a randomized, double-blind, placebo-controlled trial, 300 patients with knee osteoarthritis were assigned to receive 800 mg chondroitin sulfate (CS) or placebo once daily for 2 years. Patients receiving placebo experienced a mean joint space loss of 0.14 +/- 0.61 mm after 2 years (P = 0.001 compared with baseline), whereas patients receiving CS showed no change (0.00 +/- 0.53 mm; P not significant compared with baseline). The difference in joint space loss between the two groups was significant for mean joint space width (0.14 +/- 0.57 mm; P = 0.04) and minimum joint space width (0.12 +/- 0.52 mm; P = 0.05). There was no significant symptomatic effect on pain or function, and CS was well tolerated.

Michel BA, Stucki G, Frey D, et al. Arthritis Rheum, 2005. PMID 15751094

2005 / Randomized controlled trial

Prebiotic inulin-type fructans increased calcium absorption and bone mineralization in adolescents.

A randomized controlled trial evaluated pubertal adolescents given 8 g daily of mixed inulin-type fructans or maltodextrin placebo. Calcium absorption was significantly higher with fructans at eight weeks (difference 8.5%, P < 0.001) and one year (difference 5.9%, P = 0.04). After one year, the fructan group gained significantly more whole-body bone mineral content (difference 35 g, P = 0.03) and bone mineral density (difference 0.015 g/cm2, P = 0.01).

Abrams SA, Griffin IJ, Hawthorne KM, et al. Am J Clin Nutr, 2005. PMID 16087995

2005 / Three-way crossover trial

Calcium carbonate-fortified soymilk matched cow's milk in calcium bioavailability in women.

Twenty young women participated in a crossover trial evaluating fractional calcium absorption from 250 mg of calcium supplied as cow's milk or fortified soymilks. Absorption from calcium carbonate-fortified soymilk (0.211 +/- 0.057) did not differ significantly from cow's milk (0.217 +/- 0.040). Both provided significantly higher calcium absorption than tricalcium phosphate-fortified soymilk (0.181 +/- 0.039, P < 0.05).

Zhao Y, Martin BR, Weaver CM J Nutr, 2005. PMID 16177199

2004 / Randomized controlled trial

Soymilk with isoflavones prevented lumbar spine bone loss in postmenopausal women.

In an 89-woman randomized trial lasting two years, researchers examined the effects of soymilk with isoflavones, transdermal progesterone, or both on bone mineral density. Lumbar spine bone mineral density changes did not differ from zero with isoflavone soymilk (+1.1%) or progesterone alone (-1.1%), but controls lost -4.2% and combined treatment lost -2.8%. Femoral neck bone mineral density did not change significantly in any group.

Lydeking-Olsen E, Beck-Jensen JE, Setchell KD, et al. Eur J Nutr, 2004. PMID 15309425

2004 / Randomized controlled trial

Soy protein supplementation improved osteoarthritis symptoms and cartilage markers primarily in men.

One hundred thirty-five adults with osteoarthritis or chronic knee pain were randomized to consume 40 g of soy protein or milk-based protein daily for 3 months. Soy protein improved range of motion, pain, and quality of life compared to milk protein, but these benefits were driven by effects in men. In men, soy protein significantly raised serum IGF-I and reduced YKL-40 levels.

Arjmandi BH, Khalil DA, Lucas EA, et al. Phytomedicine, 2004. PMID 15636169

2003 / Double-blind, randomized, parallel-group trial

Soy protein supplementation reduced bone resorption and increased IGF-I more than milk protein in postmenopausal women, especially those not on HRT.

Postmenopausal women were randomly assigned to consume 40 g daily of either soy protein (SP) or milk-based protein (MBP) for 3 months. Both supplements increased serum IGF-I, but SP had a more pronounced effect than MBP, with the greatest impact (a 97% increase) seen in women not on HRT. Urinary Dpd excretion was significantly reduced by SP, but not MBP, driven by changes in women not on HRT. In addition, MBP led to a 33% increase in urinary calcium excretion, whereas SP did not.

Arjmandi BH, Khalil DA, Smith BJ, et al. J Clin Endocrinol Metab, 2003. PMID 12629084

2002 / Randomized controlled trial

Daily dried plum intake increased markers of bone formation in postmenopausal women

Fifty-eight postmenopausal women not receiving hormone replacement therapy were randomly allocated to eat either 100 g of dried plums or 75 g of dried apples each day for three months. Only dried plum intake led to significant rises in serum insulin-like growth factor-I and bone-specific alkaline phosphatase activity compared with baseline. Neither dietary regimen produced changes in serum or urinary markers of bone resorption.

Arjmandi BH, Khalil DA, Lucas EA, et al. J Womens Health Gend Based Med, 2002. PMID 11860726

2002 / Randomized controlled trial

Genistein supplementation improved bone mineral density and bone turnover markers in postmenopausal women.

A randomized controlled trial assigned 90 healthy postmenopausal women to receive hormone replacement therapy, 54 mg/day of genistein, or placebo for one year. At 12 months, genistein increased femoral neck bone mineral density by 3.6 +/- 3% and lumbar spine density by 3 +/- 2% (P < 0.001 compared to placebo). Genistein also decreased urinary pyridinium cross-links and increased bone-specific alkaline phosphatase and osteocalcin.

Morabito N, Crisafulli A, Vergara C, et al. J Bone Miner Res, 2002. PMID 12369794

2002 / 3-year randomized, placebo-controlled, double-blind study

Glucosamine sulfate retarded joint space narrowing and improved symptoms over 3 years in patients with knee osteoarthritis.

A randomized, double-blind trial assigned 202 patients with knee osteoarthritis to receive oral glucosamine sulfate (1500 mg once daily) or placebo for 3 years. After 3 years, progressive joint space narrowing was -0.19 mm (95% CI, -0.29 to -0.09 mm) with placebo, compared to no average change with glucosamine sulfate (0.04 mm; 95% CI, -0.06 to 0.14 mm; P = .001). Predefined severe narrowings (>0.5 mm) occurred in 5% of glucosamine sulfate patients compared to 14% of placebo patients (P = .05). Glucosamine sulfate also led to a 20% to 25% improvement in symptoms, showing significant final differences on the Lequesne index and WOMAC total index and subscales.

Pavelká K, Gatterová J, Olejarová M, et al. Arch Intern Med, 2002. PMID 12374520

2001 / Randomized controlled trial

Moderate energy restriction increased bone turnover and reduced bone density in women

A 6-month randomized trial evaluated 27 obese postmenopausal women assigned to moderate energy restriction or weight maintenance. In the weight-loss group, body weight decreased by 10.2 +/- 5.5% and total-body bone mineral density fell by 1.2 +/- 1.2%, differing significantly from controls (P < 0.05). Energy-restricted women also demonstrated chronically elevated markers of bone resorption and formation compared to weight maintainers (P < 0.05).

Ricci TA, Heymsfield SB, Pierson RN, et al. Am J Clin Nutr, 2001. PMID 11157334

2001 / Randomised, double-blind, placebo-controlled trial

Glucosamine sulphate prevented progressive joint-space narrowing and improved symptoms over 3 years in knee osteoarthritis patients.

In a 3-year randomized trial, 212 patients with knee osteoarthritis received either 1500 mg oral glucosamine sulphate or placebo once daily. Patients on placebo experienced progressive joint-space narrowing with a mean joint-space loss of -0.31 mm (95% CI -0.48 to -0.13), whereas patients taking glucosamine sulphate had no significant loss (-0.06 mm, 95% CI -0.22 to 0.09). WOMAC scores showed symptoms worsened slightly on placebo but improved with glucosamine sulphate, with no differences in safety or reasons for early withdrawal between groups.

Reginster JY, Deroisy R, Rovati LC, et al. Lancet, 2001. PMID 11214126

2001 / Randomized controlled trial

Ginger extract moderately reduced knee pain on standing in patients with osteoarthritis.

A 6-week randomized trial assigned 261 patients with knee osteoarthritis to receive a standardized ginger extract or placebo twice daily. Among 247 evaluable patients, 63% in the ginger group versus 50% in the placebo group achieved at least a 15 mm pain reduction on standing (p = 0.048). Mean reduction in standing pain was 24.5 mm versus 16.4 mm (p = 0.005), though mild gastrointestinal adverse events were more frequent with ginger (59 versus 21 patients).

Altman RD, Marcussen KC Arthritis Rheum, 2001. PMID 11710709

2000 / Randomized crossover trial

Ginger extract did not differ from placebo across the full crossover trial.

Patients with hip or knee osteoarthritis participated in a randomized, double-blind crossover study testing three-week periods of ginger extract, ibuprofen, and placebo. Overall rankings favored ibuprofen, followed by ginger, and then placebo for pain and the Lequesne index. Across the complete crossover analysis, ginger did not differ significantly from placebo, although exploratory testing showed an effect during the initial treatment block.

Bliddal H, Rosetzsky A, Schlichting P, et al. Osteoarthritis Cartilage, 2000. PMID 10607493

2000 / Non-randomized controlled trial (5-year follow-up)

A 5-year weighted vest plus jumping exercise program prevented significant hip bone mineral density loss in postmenopausal women.

Eighteen postmenopausal women who previously completed a 9-month intervention volunteered for a 5-year follow-up trial. Nine engaged in weighted vest plus jumping exercise three times per week for 32 weeks per year over 5 years, while nine controls remained active without the program. After 5 years, changes in BMD for exercisers were +1.54% +/- 2.37%, -0.24% +/- 1.02%, and -0.82% +/- 1.04% at the femoral neck, trochanter, and total hip, respectively, compared to decreases of -4.43% +/- 0.93%, -3.43% +/- 1.09%, and -3.80% +/- 1.03% in controls.

Snow CM, Shaw JM, Winters KM, et al. J Gerontol A Biol Sci Med Sci, 2000. PMID 10995045

1998 / Clinical trial protocol

Design overview of the Women's Health Initiative clinical trial and observational study.

The Women's Health Initiative protocol enrolled postmenopausal women aged 50 to 79 across 40 clinical centers, with an average follow-up of about 9 years. The randomized clinical trial planned to evaluate a low-fat eating pattern, hormone replacement therapy, and calcium plus vitamin D supplementation in roughly 64,500 women. An observational component enrolled approximately 100,000 additional women to assess common causes of morbidity and mortality.

Authors not listed Control Clin Trials, 1998. PMID 9492970

1997 / Randomized crossover trial

Calcium from cheese and calcium salt significantly reduced serum parathyroid hormone, while calcium from spinach and sesame seeds caused no acute response.

Nine female volunteers received 400 mg calcium from Emmental cheese, milk, sesame seeds, spinach, calcium salt, or a control meal in random order. Serum ionized calcium increased significantly after cheese (P = 0.004) or calcium salt (P = 0.05), while intact parathyroid hormone significantly declined after cheese (P = 0.002) and calcium salt (P = 0.007) versus control. Urinary calcium excretion was higher than control with cheese (141%, P = 0.001), milk (107%, P = 0.004), and calcium salt (75%, P = 0.02). Calcium from sesame seeds and spinach did not cause an acute response in calcium metabolism.

Kärkkäinen MU, Wiersma JW, Lamberg-Allardt CJ Am J Clin Nutr, 1997. PMID 9174467

1994 / Controlled, single-blind clinical trial psychological analysis

RA patients responding to a vegetarian diet held lower belief in ordinary medicine, while dietary treatment reduced psychological distress.

Researchers examined psychological parameters among 53 rheumatoid arthritis patients participating in a trial of fasting and vegetarian diet compared with 71 non-participating RA patients. Participants had higher internal and lower chance scores on the MHLCS, lower belief in ordinary medicine, and higher belief in alternative treatments. Among patients randomized to the vegetarian diet, responders did not differ from non-responders on MHLCS scores, but responders had significantly lower belief in ordinary medical treatment. General Health Questionnaire scores favoured vegetarians over omnivores and responders over non-responders, indicating dietary treatment decreased psychological distress.

Kjeldsen-Kragh J, Haugen M, Førre O, et al. Br J Rheumatol, 1994. PMID 8205407

1993 / Randomized clinical trial

Supervised exercises and arthroscopic surgery were equally effective and superior to placebo for rotator cuff disease.

A randomized clinical trial compared arthroscopic subacromial decompression, a 3- to 6-month supervised exercise regimen, and 12 sessions of placebo soft laser treatment in 125 patients with stage II impingement syndrome. After six months, both active treatments improved the condition significantly compared with placebo, but the difference in improvement in overall Neer score between surgery and exercises was not significant (4.0 [95% CI -2 to 11]; 2.0 [-1.4 to 5.4] adjusted for sex). No differences were found in duration of sick leave or daily analgesic intake, while treatment costs were higher for surgery (£720 vs £390).

Brox JI, Staff PH, Ljunggren AE, et al. BMJ, 1993. PMID 8241852

1992 / Randomized controlled trial

Daily vitamin D3 and calcium reduced hip and nonvertebral fractures in elderly women

In an 18-month randomized trial, 3,270 ambulatory women (mean age 84 years) received daily supplementation with 1.2 g elemental calcium plus 800 IU vitamin D3 or a double placebo. Calcium and vitamin D3 reduced hip fractures by 43 percent (P = 0.043) and total nonvertebral fractures by 32 percent (P = 0.015). Proximal femur bone density rose 2.7 percent with active treatment and decreased 4.6 percent in the placebo group (P < 0.001).

Chapuy MC, Arlot ME, Duboeuf F, et al. N Engl J Med, 1992. PMID 1331788